New stock news | Seven companies, including Victorspirit and Intelligent Jia, have submitted their Hong Kong IPO application materials and have been accepted by the China Securities Regulatory Commission.
Virtue Pharmaceuticals, Extreme Intelligence, Haixi New Medicine, and Jinfang Medical Port's IPO application materials have been received by the China Securities Regulatory Commission.
On February 7th, the China Securities Regulatory Commission issued the "Table of Domestic Enterprises' Overseas Securities Issuance and Listing Filing Situation (Initial Public Offering and Full Circulation) (as of February 7, 2025)". This week (February 3rd - February 7th), the IPO filing materials of Lexin Outdoor, Vital Healthcare, BUTONG GROUP, Qianyuan Weike, Jizhi Jia, Haixi New Medicine, and Jinfang Pharmaceutical Hong Kong Stock received by the China Securities Regulatory Commission.
Related Articles

OOIL (00316): Independent Non-Executive Director Su Jinliang Passes Away

LUKS GROUP (VN)(00366): Ms. Zheng Qiang, Chairman of the Board, passed away.

YU TAK INT'L (08048) appointed Bauman Man and Lin Feifei as independent non-executive directors.
OOIL (00316): Independent Non-Executive Director Su Jinliang Passes Away

LUKS GROUP (VN)(00366): Ms. Zheng Qiang, Chairman of the Board, passed away.

YU TAK INT'L (08048) appointed Bauman Man and Lin Feifei as independent non-executive directors.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


